Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ESP Pharma

ESP Pharma
2000 FOUNDED
M&A STATUS
71-80 EMPLOYEES
M&A LATEST DEAL TYPE
$486M LATEST DEAL AMOUNT
Description

Developer of specialty pharmaceutical products designed to enhance the quality of therapeutics available to healthcare professionals. The company's specialty pharmaceutical products include therapeutics for high blood pressure and angina and late-stage development specialty drugs for bone marrow transplants, enabling patients to achieve improved outcomes in the acute-care setting.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Acquirer
Primary Office
  • 2035 Lincoln Highway
  • Suite 2150
  • Edison, NJ 08817
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ESP Pharma’s full profile, request a free trial.

ESP Pharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 24-Mar-2005 $486M 0000 00000 Completed Profitable
3. Debt - General 08-Oct-2003 0000 0000 Completed Profitable
2. Early Stage VC (Series B) 16-Apr-2003 $28M Completed Profitable
1. Early Stage VC (Series A) 01-Apr-2002 $28M $28M Completed Profitable
To view this company’s complete deal history including valuation and funding, request access »

ESP Pharma Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Alta Partners Venture Capital Minority 000 0000 000000 0
Apax Partners PE/Buyout Minority 000 0000 000000 0
Cressey & Company PE/Buyout Minority 000 0000 000000 0
Domain Associates Venture Capital Minority 000 0000 000000 0
ESP Equity Partners PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »